June 2026 We are pleased to announce that Schlich has once again been recognised in the IAM Patent 1000 rankings, for patent prosecution in the United Kingdom.
In addition, Schlich attorneys George Schlich, Juliette Boynton, Alexander Bajjon, Simon Wright, David Eyre, Michael Hutchins, Andrew Clements and Carolyn Haywood are highlighted as “Recommended Individuals.”
Schlich have been recommended in the Bronze tier for patent prosecution as being:
“[…] an incredible firm and trusted choice for complex technical and procedural patent matters, delivering high-quality, commercially attuned advice. The team is lean and agile, offering a tailored, client-centric service with partners closely engaged in day-to-day communications. Drawing on experience gained at leading firms, its practitioners combine top-tier capability with a competitive pricing model. They are highly responsive, approachable and consistently deliver excellent value.”
The IAM 1000 also notes that
“The boutique has carved out a strong reputation for handling sophisticated EPO matters, combining technical depth with procedural expertise to deliver positive outcomes in highly complex areas.”
Furthermore, the IAM 1000 have individually recommended a number of Schlich attorneys.
Firm Founder George Schlich has been awarded a Silver ranking for being “a standout name for opposition and appeal proceedings, particularly in cutting-edge life sciences matters.”
Director, Simon Wright has been ranked in the Gold tier and has been described as “a strong choice for patent prosecution of cutting-edge inventions, combining deep knowledge of both the law and the underlying science.”
Director, Dr. Juliette Boynton is also awarded a Silver ranking, with recognition for her work in EPO opposition proceedings, alongside Andrew Clements, representing Glenmark Pharmaceuticals in a high profile opposition against a key Tecfidera® patent.
Dr. Andrew Clements is ranked in the Bronze tier and has been recognized particularly for his work in EPO appeal proceedings, and especially his work within an array of parallel appeal proceedings alongside other Schlich attorneys, “contributing thoughtful ideas and delivering strong submissions in oral proceedings, underpinned by both legal and scientific rigour.”
Dr. David Eyre has been awarded a Bronze ranking that highlights his work this year advising a startup on protecting their energy-efficient heating and lighting systems that are driven by a novel user comfort parameter.
Dr. Michael Hutchins has also been awarded a Bronze ranking, and has been particularly commended as being “a trusted partner to Sentinel Oncology” in providing strategic guidance on patentability, freedom to operate and portfolio development.
Finally, Director Alexander Bajjon and Dr. Carolyn Haywood have both been individually recommended in the ‘Next Generation’ category.
We are incredibly proud of our team and would like to thank everyone for their hard work and commitment in earning these recommendations. Finally, we would especially like to thank our named and anonymous referees for their generous testimonials.
